Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, Williams HC; Surgery versus Imiquimod for Nodular Superficial basal cell carcinoma (SINS) study group. Bath-Hextall F, et al. Among authors: ozolins m. Lancet Oncol. 2014 Jan;15(1):96-105. doi: 10.1016/S1470-2045(13)70530-8. Epub 2013 Dec 11. Lancet Oncol. 2014. PMID: 24332516 Free article. Clinical Trial.
A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes.
Fortnum H, Ukoumunne OC, Hyde C, Taylor RS, Ozolins M, Errington S, Zhelev Z, Pritchard C, Benton C, Moody J, Cocking L, Watson J, Roberts S. Fortnum H, et al. Among authors: ozolins m. Health Technol Assess. 2016 May;20(36):1-178. doi: 10.3310/hta20360. Health Technol Assess. 2016. PMID: 27169435 Free PMC article.
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.
Williams HC, Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PSJ; Surgery Versus Imiquimod for Nodular and Superficial Basal Cell Carcinoma (SINS) Study Group. Williams HC, et al. Among authors: ozolins m. J Invest Dermatol. 2017 Mar;137(3):614-619. doi: 10.1016/j.jid.2016.10.019. Epub 2016 Dec 5. J Invest Dermatol. 2017. PMID: 27932240 Free article. Clinical Trial.
A directly comparative two-gate case-control diagnostic accuracy study of the pure tone screen and HearCheck screener tests for identifying hearing impairment in school children.
Ukoumunne OC, Hyde C, Ozolins M, Zhelev Z, Errington S, Taylor RS, Benton C, Moody J, Cocking L, Watson J, Fortnum H. Ukoumunne OC, et al. Among authors: ozolins m. BMJ Open. 2017 Jul 11;7(7):e017258. doi: 10.1136/bmjopen-2017-017258. BMJ Open. 2017. PMID: 28701413 Free PMC article.
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands.
Foss A, Haydock R, Childs M, Duley LM, Empeslidis T, Dhar-Munshi S, Montgomery AA, Ogollah R, Ozolins M, Tesha P, Mitchell E. Foss A, et al. Among authors: ozolins m. BMJ Open Ophthalmol. 2020 Dec 8;5(1):e000588. doi: 10.1136/bmjophth-2020-000588. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 33344775 Free PMC article.
16 results